Radiofrequency Ablation for Tumor-Related Massive Hematuria

Ziv Neeman, Shawn Sarin, Jonathan Coleman, Tito Fojo, Bradford J. WoodJournal of Vascular and Interventional Radiology 2005 · DOI

TL;DR

This paper explores radiofrequency (RF) ablation as a novel treatment for massive, transfusion-dependent hematuria caused by kidney tumors, particularly in patients with compromised renal function or other comorbidities. The study demonstrates that RF ablation can effectively and durably stop bleeding, offering a less invasive alternative to traditional methods like embolization or surgery.

What Problem Does This Paper Address?

Massive hematuria (bleeding in the urine) stemming from kidney tumors is a serious complication that can lead to significant blood loss, requiring frequent transfusions and potentially causing severe anemia or even hypotension. For patients with pre-existing renal insufficiency, a solitary kidney, or other serious health issues, traditional treatments like surgical removal of the kidney (nephrectomy) or angiographic embolization (blocking blood vessels) carry substantial risks. Embolization, while less invasive than surgery, can be non-selective, potentially damaging healthy kidney tissue, and carries the risk of contrast-induced nephropathy, which is particularly dangerous for already compromised kidneys. This leaves a critical unmet need for a minimally invasive, nephron-sparing treatment option for these challenging cases.

Methods

The study employed a Radionics Cool-Tip 200-W RF ablation system under conscious sedation. Procedures were guided by ultrasound (US) and computed tomography (CT) in most cases, with one instance using US guidance alone. The RF probes were strategically placed at the interface between the tumor and the collecting system of the kidney. This approach aims to cauterize the bleeding vessels without necessarily destroying the entire tumor, preserving renal function. The technique involved targeting the tissue immediately adjacent to the collecting system, with the probe tip several millimeters away from the direct junction.

Datasets

Not discussed in the paper. The study presents a case series of four patients.

Key Insights and Ideas

  • Targeting the Interface is Key: The study suggests that RF ablation doesn't need to completely destroy the tumor to be effective. Targeting the interface between the tumor and the collecting system appears to be sufficient to stop bleeding, likely by destroying the tumor's connection to the urinary tract.
  • RF Ablation as a Viable Alternative: For patients who are poor candidates for surgery or for whom conventional embolization has failed or is too risky, RF ablation emerges as a promising therapeutic option.
  • Nephron-Sparing Potential: The observed improvement in serum creatinine levels post-ablation highlights the potential of RF ablation to preserve renal function, a critical advantage over more destructive treatments.
  • Durability of Effect: The study reports durable clinical effects, with hematuria resolving and not recurring in most cases over a significant follow-up period.

Key Results

  • Effective Hematuria Control: All four patients experienced resolution of gross hematuria within 24-48 hours of RF ablation.
  • Reduced Transfusion Needs: No patient required further transfusions for hematuria in the follow-up period.
  • Improved Renal Function: Creatinine levels generally improved or remained stable after RF ablation, indicating preservation of renal function.
  • Durable Response: The study reported a mean follow-up of 12 months (range 8-24 months), with durable clinical effects observed.
  • Transient Recurrence: Two patients experienced isolated, transient episodes of gross hematuria recurrence, which resolved without further intervention.
  • Minimal Complications: No major complications were encountered. One patient experienced transient suprapubic distention and anuria, managed with manual bladder irrigation.
  • Pain Management: Post-procedure pain was generally modest and manageable with oral medications, with one patient experiencing dramatic resolution of pre-existing severe pain.

Limitations and Future Work

The authors acknowledge that drawing broad conclusions from a short retrospective series of four patients is difficult. They suggest that further validation studies are needed. The potential risk of fistula or urinoma exists due to the proximity of the collecting system to the target, although this is noted as uncommon. Future work could focus on larger prospective studies to further validate the efficacy and safety of RF ablation for this specific indication and to refine targeting strategies. Pre-ablation imaging (CT and MR) to precisely localize the bleeding site is also highlighted as important for optimizing targeting, especially in cases of large or multifocal tumors.

Summary updated

BibTeX
@article{neeman2005radiofrequency,
  author = {Ziv Neeman and Shawn Sarin and Jonathan Coleman and Tito Fojo and Bradford J. Wood},
  title = {{Radiofrequency Ablation for Tumor-Related Massive Hematuria}},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2005},
  doi = {10.1097/01.rvi.0000147076.02176.13},
}
Figure